| 03.10.2024 15:45 | WPP, TSCO, SEC | UK dividends calendar - next 7 days | Alliance |
| 03.10.2024 09:39 | SFOR, OMU, MARS | LONDON BROKER RATINGS: Morgan Stanley cuts BAT; boohoo gets buy rating | Alliance |
| 01.10.2024 15:00 | GSK | Total Voting Rights | RNS |
| 01.10.2024 10:03 | GSK, HLN | UPDATE: Pfizer cuts stake in Haleon to 15% with GBP2.7 billion sale | Alliance |
| 01.10.2024 09:40 | CWR, ASC, KIST | LONDON BROKER RATINGS: Barclays cuts Smiths Group to 'equal weight' | Alliance |
| 30.09.2024 21:59 | GSK, HLN | TOP NEWS: Pfizer to raise around GBP2.7 billion from Haleon stake sale | Alliance |
| 24.09.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 24.09.2024 09:16 | GSK | TOP NEWS: GSK celebrates positive EU opinion of liquid Menveo vaccine | Alliance |
| 24.09.2024 07:00 | GSK | Positive EU opinion for GSK liquid Menveo vaccine | RNS |
| 18.09.2024 14:00 | GSK | GSK reaches further two settlements regarding Zantac | Alliance |
| 18.09.2024 13:20 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
| 17.09.2024 09:18 | GSK | GSK says Blenrep combinations accepted for review in Japan | Alliance |
| 17.09.2024 07:00 | GSK | Japan Filing Acceptance: Blenrep Multiple Myeloma | RNS |
| 13.09.2024 09:14 | GSK | GSK myeloma treatment given breakthrough therapy designation in China | Alliance |
| 12.09.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 12.09.2024 08:31 | GSK | TOP NEWS: GSK welcomes positive findings on possible flu treatment | Alliance |
| 12.09.2024 07:00 | GSK | Positive mRNA flu vaccine Phase II headline data | RNS |
| 11.09.2024 17:27 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
| 11.09.2024 15:30 | GSK | Change of Registered Office | RNS |
| 11.09.2024 09:55 | GSK | GSK stresses need for innovation as herpes vaccine fails to progress | Alliance |
| 11.09.2024 07:00 | GSK | Update on phase I/II therapeutic HSV vaccine trial | RNS |
| 09.09.2024 22:02 | CYAN, CLC, ENET | TRADING UPDATES: Live Co fails to reach agreement with creditor | Alliance |
| 09.09.2024 14:30 | GSK | Depemokimab late-breaking data presented at ERS | RNS |
| 06.09.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 06.09.2024 11:47 | GSK, OXB, IES | EXECUTIVE CHANGES: Invinity replaces CEO; Gulf Keystone chair dies | Alliance |
| 06.09.2024 09:38 | GSK | GSK hails positive results of Nucala clinical trials in lung disease | Alliance |
| 06.09.2024 07:00 | GSK | Positive Phase III results for Nucala in COPD | RNS |
| 02.09.2024 15:00 | GSK | Total Voting Rights | RNS |
| 29.08.2024 10:37 | GSK | TOP NEWS: GSK hails EU approval of RSV jab Arexy for 50-59 year olds | Alliance |
| 29.08.2024 07:00 | GSK | EMA approval on Arexvy for 50-59 at risk | RNS |
| 28.08.2024 09:14 | GSK | TOP NEWS: GSK hails approval in Japan; US court decision on Zantac | Alliance |
| 28.08.2024 07:10 | GSK | SENKU Designation for Bepirovirsen in Japan | RNS |
| 28.08.2024 07:05 | GSK | Nucala approved in Japan for use in CRSwNP | RNS |
| 28.08.2024 07:00 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
| 21.08.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 20.08.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 20.08.2024 09:29 | GSK | TOP NEWS: GSK celebrates US FDA breakthrough therapy designation | Alliance |
| 20.08.2024 07:00 | GSK | B7-H3 ADC US FDA Breakthrough Therapy Designation | RNS |
| 16.08.2024 07:00 | GSK | TOP NEWS: GSK celebrates Florida state court ruling in Zantac case | Alliance |
| 16.08.2024 07:00 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
| 12.08.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 08.08.2024 16:09 | GSEO, TET, TIFS | UK dividends calendar - next 7 days | Alliance |
| 06.08.2024 09:06 | GSK | GSK celebrates Illinois jury verdict on Zantac in favour of company | Alliance |
| 06.08.2024 07:00 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
| 02.08.2024 09:54 | ITM, RCH, JET2 | LONDON BROKER RATINGS: Jefferies likes Frasers; Peel cuts Man Group | Alliance |
| 02.08.2024 06:54 | GSK | GSK celebrates US FDA backing for expanded use of cancer drug Jemperli | Alliance |
| 01.08.2024 15:00 | GSK | Total Voting Rights | RNS |
| 01.08.2024 09:55 | JET, LTG, CRE | LONDON BROKER RATINGS: Berenberg cuts Crest Nicholson to 'hold' | Alliance |
| 31.07.2024 09:34 | GSK | TOP NEWS: GSK's raised outlook clouded by weak vaccines, Shingrix drop | Alliance |
| 29.07.2024 08:48 | GSK | TOP NEWS: GSK hails European opinion on Arexvy for people in their 50s | Alliance |
| 24.07.2024 14:45 | SHC, RIO, RCDO | UK earnings, trading statements calendar - next 7 days | Alliance |
| 23.07.2024 12:07 | GSK | GSK announces promising trial data for ViiV Healthcare HIV drugs | Alliance |
| 19.07.2024 10:36 | GSK | Blenrep EMA Filing Acceptance | RNS |
| 19.07.2024 08:12 | GSK | GSK drug for multiple myeloma accepted for European regulatory review | Alliance |
| 18.07.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 16.07.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 15.07.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 12.07.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 08.07.2024 09:27 | RIO, INF, GSK | LONDON BROKER RATINGS: UBS cuts GSK; RBC raises Melrose Industries | Alliance |
| 05.07.2024 09:14 | SCT, BYIT, BVIC | LONDON BROKER RATINGS: Jefferies cuts Softcat to 'underperform' | Alliance |
| 04.07.2024 12:13 | SMWH, UAV, SUPR | UK dividends calendar - next 7 days | Alliance |
| 03.07.2024 09:22 | GSK | TOP NEWS: GSK inks licensing deal with CureVac for flu and Covid drugs | Alliance |
| 03.07.2024 07:00 | GSK | GSK and CureVac collaboration restructured | RNS |
| 01.07.2024 15:00 | GSK | Total Voting Rights | RNS |
| 28.06.2024 19:43 | GSK | IN BRIEF: GSK reaches settlement over Zantac case in Illinois | Alliance |
| 28.06.2024 17:37 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
| 24.06.2024 08:55 | GSK | TOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EU | Alliance |
| 24.06.2024 07:05 | GSK | Omjjara approved in Japan for myelofibrosis | RNS |
| 24.06.2024 07:00 | GSK | EMA validates Jemperli marketing authorisation | RNS |
| 21.06.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 12.06.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 11.06.2024 09:32 | GSK | TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware | Alliance |
| 11.06.2024 07:00 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
| 10.06.2024 19:00 | GSK | TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois | Alliance |
| 10.06.2024 18:27 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
